Ensysce Biosciences (ENSCW) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to -$1.29.
- Ensysce Biosciences' EPS (Weighted Average and Diluted) fell 22900.0% to -$1.29 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.4, marking a year-over-year increase of 9175.68%. This contributed to the annual value of -$11.45 for FY2024, which is 8373.85% up from last year.
- As of Q3 2025, Ensysce Biosciences' EPS (Weighted Average and Diluted) stood at -$1.29, which was down 22900.0% from -$0.79 recorded in Q2 2025.
- In the past 5 years, Ensysce Biosciences' EPS (Weighted Average and Diluted) ranged from a high of $1.0 in Q3 2024 and a low of -$61.58 during Q3 2022
- In the last 5 years, Ensysce Biosciences' EPS (Weighted Average and Diluted) had a median value of -$1.74 in 2025 and averaged -$12.27.
- Per our database at Business Quant, Ensysce Biosciences' EPS (Weighted Average and Diluted) crashed by 860259.0% in 2022 and then soared by 21494.25% in 2024.
- Quarter analysis of 5 years shows Ensysce Biosciences' EPS (Weighted Average and Diluted) stood at -$0.54 in 2021, then plummeted by 5608.92% to -$30.69 in 2022, then rose by 24.35% to -$23.22 in 2023, then soared by 77.99% to -$5.11 in 2024, then skyrocketed by 74.75% to -$1.29 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$1.29 for Q3 2025, versus -$0.79 for Q2 2025 and -$1.39 for Q1 2025.